|
US7763609B2
(en)
|
2003-12-15 |
2010-07-27 |
Schering Corporation |
Heterocyclic aspartyl protease inhibitors
|
|
ES2537898T3
(es)
*
|
2005-10-25 |
2015-06-15 |
Shionogi & Co., Ltd. |
Derivados de aminotiazolidina y aminotetrahidrotiazepina como inhibidores de BACE 1
|
|
EP2151435A4
(en)
|
2007-04-24 |
2011-09-14 |
Shionogi & Co |
PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALZHEIMER'S DISEASE
|
|
KR20100017255A
(ko)
*
|
2007-04-24 |
2010-02-16 |
시오노기 앤드 컴파니, 리미티드 |
환식기로 치환된 아미노다이하이드로싸이아진 유도체
|
|
SI2233474T1
(sl)
*
|
2008-01-18 |
2015-11-30 |
Eisai R&D Management Co., Ltd. |
Kondenziran derivat aminodihidrotiazina
|
|
EP2305672B1
(en)
|
2008-06-13 |
2019-03-27 |
Shionogi & Co., Ltd. |
SULFUR-CONTAINING HETEROCYCLIC DERIVATIVE HAVING ß-SECRETASE-INHIBITING ACTIVITY
|
|
WO2010013794A1
(en)
*
|
2008-07-28 |
2010-02-04 |
Eisai R&D Management Co., Ltd. |
Spiroaminodihydrothiazine derivatives
|
|
ES2539859T3
(es)
*
|
2008-09-30 |
2015-07-06 |
Eisai R&D Management Co., Ltd. |
Nuevo derivado de aminodihidrotiazina condensado
|
|
CN102186841A
(zh)
|
2008-10-22 |
2011-09-14 |
盐野义制药株式会社 |
具有bace1抑制活性的2-氨基嘧啶-4-酮及2-氨基吡啶衍生物
|
|
GB0912777D0
(en)
|
2009-07-22 |
2009-08-26 |
Eisai London Res Lab Ltd |
Fused aminodihydropyrimidone derivatives
|
|
GB0912778D0
(en)
|
2009-07-22 |
2009-08-26 |
Eisai London Res Lab Ltd |
Fused aminodihydro-oxazine derivatives
|
|
WO2011044184A1
(en)
|
2009-10-08 |
2011-04-14 |
Schering Corporation |
Pentafluorosulfur imino heterocyclic compounds as bace-1 inhibitors, compositions, and their use
|
|
WO2011044187A1
(en)
|
2009-10-08 |
2011-04-14 |
Schering Corporation |
Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use
|
|
EP2485920B1
(en)
|
2009-10-08 |
2016-04-27 |
Merck Sharp & Dohme Corp. |
Pentafluorosulfur imino heterocyclic compounds as bace-1 inhibitors, compositions, and their use
|
|
UA108363C2
(uk)
|
2009-10-08 |
2015-04-27 |
|
Похідні імінотіадіазиндіоксиду як інгібітори bace, композиція на їх основі і їх застосування
|
|
RU2012129168A
(ru)
|
2009-12-11 |
2014-01-20 |
Сионоги Энд Ко. Лтд. |
Производные оксазина
|
|
WO2011071109A1
(ja)
*
|
2009-12-11 |
2011-06-16 |
塩野義製薬株式会社 |
アミノ基を有する縮合ヘテロ環化合物
|
|
CN102933564B
(zh)
|
2010-06-09 |
2015-07-22 |
詹森药业有限公司 |
用作β-分泌酶(BACE)抑制剂的5,6-二氢-2H-[1,4]噁嗪-3-基-胺衍生物
|
|
CN103261199A
(zh)
|
2010-10-29 |
2013-08-21 |
盐野义制药株式会社 |
萘啶衍生物
|
|
JP5766198B2
(ja)
|
2010-10-29 |
2015-08-19 |
塩野義製薬株式会社 |
縮合アミノジヒドロピリミジン誘導体
|
|
WO2012085038A1
(en)
|
2010-12-22 |
2012-06-28 |
Janssen Pharmaceutica Nv |
5,6-DIHYDRO-IMIDAZO[1,2-a]PYRAZIN-8-YLAMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE)
|
|
GB201100181D0
(en)
*
|
2011-01-06 |
2011-02-23 |
Eisai Ltd |
Fused aminodihydrothiazine derivatives
|
|
GB201101140D0
(en)
|
2011-01-21 |
2011-03-09 |
Eisai Ltd |
Fused aminodihydrothiazine derivatives
|
|
GB201101139D0
(en)
|
2011-01-21 |
2011-03-09 |
Eisai Ltd |
Fused aminodihydrothiazine derivatives
|
|
ES2624288T3
(es)
*
|
2011-01-21 |
2017-07-13 |
Eisai R&D Management Co., Ltd. |
Métodos y compuestos útiles en la síntesis de derivados de aminodihidrotiazina condensados
|
|
JP5853035B2
(ja)
|
2011-03-09 |
2016-02-09 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプＪａｎｓｓｅｎ Ｐｈａｒｍａｃｅｕｔｉｃａ Ｎａａｍｌｏｚｅ Ｖｅｎｎｏｏｔｓｃｈａｐ |
β−セクレターゼ（ＢＡＣＥ）の阻害剤として有用な３，４−ジヒドロ−ピロロ［１，２−ａ］ピラジン−１−イルアミン誘導体
|
|
WO2012138590A1
(en)
|
2011-04-07 |
2012-10-11 |
Merck Sharp & Dohme Corp. |
Pyrrolidine-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use
|
|
WO2012138734A1
(en)
|
2011-04-07 |
2012-10-11 |
Merck Sharp & Dohme Corp. |
C5-c6 oxacyclic-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use
|
|
WO2012147763A1
(ja)
|
2011-04-26 |
2012-11-01 |
塩野義製薬株式会社 |
オキサジン誘導体およびそれを含有するｂａｃｅ１阻害剤
|
|
US8604024B2
(en)
|
2011-05-24 |
2013-12-10 |
Bristol-Myers Squibb Company |
Compounds for the reduction of beta-amyloid production
|
|
TW201302763A
(zh)
|
2011-05-24 |
2013-01-16 |
必治妥美雅史谷比公司 |
用於減少β－類澱粉產生之化合物
|
|
US8927535B2
(en)
*
|
2011-07-06 |
2015-01-06 |
Hoffman-La Roche Inc. |
Cyclopropyl-fused-1,3-thiazepines as BACE1 and/or BACE2 inhibitors
|
|
EP2747769B1
(en)
|
2011-08-22 |
2017-08-02 |
Merck Sharp & Dohme Corp. |
2-spiro-substituted iminothiazines and their mono-and dioxides as bace inhibitors, compositions and their use
|
|
EP2751116B1
(en)
|
2011-08-31 |
2016-10-12 |
Pfizer Inc |
Hexahydropyrano [3,4-d][1,3]thiazin-2-amine compounds
|
|
JO3143B1
(ar)
|
2012-04-03 |
2017-09-20 |
Lilly Co Eli |
مركبات تتراهيدرو بيرولو ثيازين
|
|
US9227942B2
(en)
|
2012-04-27 |
2016-01-05 |
Eisai R&D Management Co., Ltd. |
Method for producing 5-(difluoromethyl)pyrazine-2-carboxylic acid and production intermediate thereof
|
|
CA2872154C
(en)
|
2012-05-04 |
2016-08-23 |
Pfizer Inc. |
Heterocyclic substituted hexahydropyrano [3,4-d] [1,3] thiazin-2-amine compounds as inhibitors of app, bace1 and bace2
|
|
GB201212871D0
(en)
|
2012-07-20 |
2012-09-05 |
Eisai Ltd |
Novel compounds
|
|
US9260455B2
(en)
|
2012-09-20 |
2016-02-16 |
Pfizer Inc. |
Alkyl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
|
|
EP2912035A4
(en)
|
2012-10-24 |
2016-06-15 |
Shionogi & Co |
DERIVATIVES OF DIHYDROOXAZINE OR OXAZEPINE HAVING BACE1 INHIBITING ACTIVITY
|
|
PL2912041T3
(pl)
|
2012-10-26 |
2017-06-30 |
Eli Lilly And Company |
Pochodne tetrahydropirolotiazyny stanowiące inhibitory BACE
|
|
EP2931731A1
(en)
|
2012-12-11 |
2015-10-21 |
Pfizer Inc. |
Hexahydropyrano [3,4-d][1,3]thiazin-2-amine compounds as inhibitors of bace1
|
|
WO2014098831A1
(en)
|
2012-12-19 |
2014-06-26 |
Bristol-Myers Squibb Company |
4,6-diarylaminothiazines as bace1 inhibitors and their use for the reduction of beta-amyloid production
|
|
US9403846B2
(en)
|
2012-12-19 |
2016-08-02 |
Pfizer Inc. |
Carbocyclic- and heterocyclic-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
|
|
WO2014120658A1
(en)
|
2013-01-29 |
2014-08-07 |
Amgen Inc. |
Fused multicyclic 3-amino-5,6-dihydro-2h-1,4-thiazine derivatives and their use as beta-secretase inhibitors
|
|
US10202355B2
(en)
|
2013-02-12 |
2019-02-12 |
Buck Institute For Research On Aging |
Hydantoins that modulate bace-mediated app processing
|
|
CA2897678A1
(en)
|
2013-02-13 |
2014-08-21 |
Pfizer Inc. |
Heteroaryl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
|
|
US9233981B1
(en)
|
2013-02-15 |
2016-01-12 |
Pfizer Inc. |
Substituted phenyl hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
|
|
AU2014223334C1
(en)
*
|
2013-03-01 |
2018-10-18 |
Amgen Inc. |
Perfluorinated 5,6-dihydro-4H-1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
|
|
AP2015008716A0
(en)
|
2013-03-08 |
2015-09-30 |
Amgen Inc |
Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
|
|
TWI593692B
(zh)
|
2013-03-12 |
2017-08-01 |
美國禮來大藥廠 |
四氫吡咯并噻嗪化合物
|
|
ES2627633T3
(es)
|
2013-06-12 |
2017-07-28 |
Janssen Pharmaceutica N.V. |
Derivados de 4-amino-6-fenil-5,6-dihidroimidazo[1,5-a]piracin-3(2H)-ona como inhibidores de beta-secretasa (BACE)
|
|
CN105324383B
(zh)
|
2013-06-12 |
2017-10-31 |
詹森药业有限公司 |
作为β‑分泌酶(BACE)抑制剂的4‑氨基‑6‑苯基‑6,7‑二氢[1,2,3]三唑并[1,5‑A]吡嗪衍生物
|
|
JO3318B1
(ar)
*
|
2013-06-18 |
2019-03-13 |
Lilly Co Eli |
مثبطات bace
|
|
US9096615B2
(en)
|
2013-07-30 |
2015-08-04 |
Amgen Inc. |
Bridged bicyclic amino thiazine dioxide compounds as inhibitors of beta-secretase and methods of use thereof
|
|
CN106459088A
(zh)
|
2014-04-10 |
2017-02-22 |
辉瑞公司 |
2‑氨基‑6‑甲基‑4，4a，5，6‑四氢吡喃并[3，4‑d][1，3]噻嗪‑8a(8H)‑基‑1，3‑噻唑‑4‑基酰胺
|
|
US9550762B2
(en)
|
2014-08-08 |
2017-01-24 |
Amgen, Inc. |
Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use
|
|
MA40941A
(fr)
|
2014-11-10 |
2017-09-19 |
H Lundbeck As |
2-amino-5,5-difluoro-6-(fluorométhyl)-6-phényl-3,4,5,6-tétrahydropyridines comme inhibiteurs de bace1
|
|
CR20170187A
(es)
|
2014-11-10 |
2018-02-01 |
H Lundbeck As |
2-Amino-3,5-difluoro-6-metil-6-fenil-3,4,5,6-tetrahidropiridinas en calidad de inhibidores de BACE1 para el tratamiento de la enfermedad de Alzheimer
|
|
JO3458B1
(ar)
|
2014-11-10 |
2020-07-05 |
H Lundbeck As |
2- أمينو-6- (دايفلوروميثيل) – 5، 5- ديفلورو-6-فينيل-3،4، 5، 6-تيتراهيدروبيريدين كمثبطات bace1
|
|
KR20170095881A
(ko)
|
2014-12-18 |
2017-08-23 |
얀센 파마슈티카 엔.브이. |
베타―세크레타제의 ２,３,４,５―테트라히드로피리딘―６―아민 및 ３,４―디히드로―２ｈ―피롤―５―아민 화합물 억제제
|
|
AR103680A1
(es)
|
2015-02-23 |
2017-05-24 |
Lilly Co Eli |
Inhibidores selectivos de bace1
|
|
CN107257795A
(zh)
*
|
2015-03-19 |
2017-10-17 |
伊莱利利公司 |
选择性bace1抑制剂
|
|
AR104241A1
(es)
|
2015-04-29 |
2017-07-05 |
Lilly Co Eli |
Derivados de tetrahidrofuro tiazina como inhibidores de bace1 selectivos
|
|
WO2017024180A1
(en)
|
2015-08-06 |
2017-02-09 |
Amgen Inc. |
Vinyl fluoride cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use
|
|
TW201717948A
(zh)
|
2015-08-10 |
2017-06-01 |
Ｈ 朗德貝克公司 |
包括給予２－胺基－３，５，５－三氟－３，４，５，６－四氫吡啶的聯合治療
|
|
HK1253372A1
(zh)
|
2015-08-12 |
2019-06-14 |
H‧隆德贝克有限公司 |
作为bace1抑制剂的2-氨基-3-氟-3-(氟甲基)-6-甲基-6-苯基-3，4，5，6-四氢吡啶
|
|
CN107849056A
(zh)
*
|
2015-08-12 |
2018-03-27 |
H.隆德贝克有限公司 |
Bace1抑制剂2‑氨基‑7a‑苯基‑3,4,4a,5,7,7a‑六氢呋喃并[3,4‑b]吡啶
|
|
WO2017051303A1
(en)
|
2015-09-24 |
2017-03-30 |
Pfizer Inc. |
Tetrahydropyrano[3,4-d][1,3]oxazin derivatives and their use as bace inhibitors
|
|
WO2017051294A1
(en)
|
2015-09-24 |
2017-03-30 |
Pfizer Inc. |
N-[2-(3-amino-2,5-dimethyl-1,1-dioxido-5,6-dihydro-2h-1,2,4-thiadiazin-5-yl)-1,3-thiazol-4-yl] amides useful as bace inhibitors
|
|
EP3353183A1
(en)
*
|
2015-09-24 |
2018-08-01 |
Pfizer Inc |
N-[2-(2-amino-6,6-disubstituted-4, 4a, 5, 6-tetrahydropyrano [3,4-d][1,3]thiazin-8a (8h)-yl) -1, 3-thiazol-4-yl]amides
|
|
TWI675034B
(zh)
*
|
2016-05-20 |
2019-10-21 |
美商美國禮來大藥廠 |
四氫呋喃并<img align="absmiddle" height="18px" width="27px" file="d10999.TIF" alt="其他非圖式 ed10999.png" img-content="tif" orientation="portrait" inline="yes" giffile="ed10999.png"></img>化合物及其作為選擇性ＢＡＣＥ１抑制劑之用途
|
|
MX2019005247A
(es)
*
|
2016-11-04 |
2019-06-24 |
Janssen Pharmaceutica Nv |
Compuestos 4,4a,5,7-tetrahidro-3h-furo[3,4-b]piridinilicos.
|
|
WO2018112086A1
(en)
|
2016-12-15 |
2018-06-21 |
Amgen Inc. |
Cyclopropyl fused thiazine derivatives as beta-secretase inhibitors and methods of use
|
|
WO2018112084A1
(en)
|
2016-12-15 |
2018-06-21 |
Amgen Inc. |
Bicyclic thiazine and oxazine derivatives as beta-secretase inhibitors and methods of use
|
|
CA3047290A1
(en)
|
2016-12-15 |
2018-06-21 |
Amgen Inc. |
1,4-thiazine dioxide and 1,2,4-thiadiazine dioxide derivatives as beta-secretase inhibitors and methods of use
|
|
MX388697B
(es)
|
2016-12-15 |
2025-03-20 |
Amgen Inc |
Derivados de tiazina como inhibidores de beta-secretasa y metodos de uso.
|
|
WO2018112081A1
(en)
|
2016-12-15 |
2018-06-21 |
Amgen Inc. |
Oxazine derivatives as beta-secretase inhibitors and methods of use
|
|
MX2019010649A
(es)
*
|
2017-03-07 |
2019-10-21 |
Janssen Pharmaceutica Nv |
Inhibidores de beta secretasa.
|
|
CA3051779A1
(en)
*
|
2017-03-07 |
2018-09-13 |
Janssen Pharmaceutica Nv |
Inhibitors of beta secretase
|
|
EP3592751A1
(en)
*
|
2017-03-07 |
2020-01-15 |
Janssen Pharmaceutica NV |
Inhibitors of beta secretase
|
|
EA201992055A1
(ru)
*
|
2017-09-07 |
2020-01-30 |
Янссен Фармацевтика Нв |
Ингибиторы бета-секретазы
|
|
EA201992076A1
(ru)
*
|
2017-09-07 |
2020-03-19 |
Янссен Фармацевтика Нв |
Ингибиторы бета-секретазы
|
|
EA201992108A1
(ru)
*
|
2017-09-07 |
2020-01-27 |
Янссен Фармацевтика Нв |
Ингибиторы бета-секретазы
|
|
CN110590517A
(zh)
*
|
2019-09-24 |
2019-12-20 |
武汉嘉诺康医药技术有限公司 |
一种3，4-二羟基-2′-氯苯乙酮的制备方法
|